HCA Healthcare, Inc. (HCA) Q4 FY25 Earnings Call

$15.55-$16.45 billion adjusted EBITDA guidance includes $400 million resiliency savings against $600-$900 million exchange headwinds.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-01-28
Length62 minutes
EPS$8.01
EPS consensus$7.36
Revenue$19.5B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q3 FY25 · Q2 FY25 · Q4 FY24 · Q3 FY24 · Q2 FY24

All HCA earnings · Back to HCA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.